FDA Approves Pfizer COVID Vaccine For Ages 6 Months to Age 4
Pfizer Inc. and BioNTech SE announced the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine as a three 3-µg dose series for children 6 months through 4 years of age (also referred to as 6 months to less than 5 years of age). “Tens of millions of older …
FDA Approves Pfizer COVID Vaccine For Ages 6 Months to Age 4 Read More »